Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.33 USD | -2.94% | -2.94% | -56.41% |
May. 13 | PaxMedica, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 06 | PaxMedica, Inc.(NasdaqCM:PXMD) dropped from S&P TMI Index | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.57M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.31
x | P/E ratio 2025 * |
-
| Employees | 7 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.4% |
1 day | -2.94% | ||
1 week | -2.94% | ||
Current month | -0.06% | ||
1 month | +4.10% | ||
3 months | -51.43% | ||
6 months | -60.87% | ||
Current year | -56.41% |
Managers | Title | Age | Since |
---|---|---|---|
Howard Weisman
CEO | Chief Executive Officer | 64 | 20-03-03 |
Stephen Sheldon
DFI | Director of Finance/CFO | 44 | 22-06-30 |
David Hough
CTO | Chief Tech/Sci/R&D Officer | 67 | 23-08-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 78 | 22-09-30 | |
Howard Weisman
CEO | Chief Executive Officer | 64 | 20-03-03 |
Zachary Rome
BRD | Director/Board Member | 40 | 19-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-04 | 0.33 | -2.94% | 67,528 |
24-06-03 | 0.34 | +2.97% | 116,981 |
24-05-31 | 0.3302 | -8.28% | 46,659 |
24-05-30 | 0.36 | +11.80% | 72,281 |
24-05-29 | 0.322 | -5.29% | 66,646 |
Delayed Quote OTC Markets, June 04, 2024 at 03:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.41% | 2.57M | |
+46.19% | 55.7B | |
-6.14% | 39.57B | |
+39.19% | 39.91B | |
-6.65% | 28.16B | |
+12.33% | 26.3B | |
-21.78% | 18.94B | |
-0.35% | 12.12B | |
+24.18% | 12.12B | |
+28.38% | 12.17B |
- Stock Market
- Equities
- PXMD Stock